Hézode, C., Lebray, P., De Ledinghen, V., Zoulim, F., Di Martino, V., Boyer, N., Larrey, D., Botta‐Fridlund, D., Silvain, C., Fontaine, H., D'Alteroche, L., Leroy, V., Bourliere, M., Hubert‐Fouchard, I., Guyader, D., Rosa, I., Nguyen‐Khac, E., Fedchuk, L., Akremi, R., Bennai, Y., Filipovics, A., Zhao, Y., & Bronowicki, J. (2017). daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme. Liver international, 37, 1314–1324. http://access.bl.uk/ark:/81055/vdc_100049405722.0x000030